Impact of the PNPLA3 genotype on the risk of hepatocellular carcinoma after hepatitis C virus eradication-Reference-Cited by-同舟云学术

Impact of the PNPLA3 genotype on the risk of hepatocellular carcinoma after hepatitis C virus eradication

Published:2022-06-11 Issue:10 Volume:94 Page:5007-5014
ISSN:0146-6615
Container-title:Journal of Medical Virology
language:en
Short-container-title:Journal of Medical Virology

Author:

Ohta Azusa¹²^ORCID,Ogawa Eiichi¹²^ORCID,Murata Masayuki²,Matsumoto Yuji¹²,Yamasaki Sho¹²,Ikezaki Hiroaki²³,Furusyo Norihiro⁴

Affiliation:

1. Department of Environmental Medicine and Infectious Disease Kyushu University Graduate School of Medical Sciences Fukuoka Japan

2. Department of General Internal Medicine Kyushu University Hospital Fukuoka Japan

3. Department of Comprehensive General Internal Medicine, Kyushu University Graduate School of Medical Sciences Faculty of Medical Sciences Fukuoka Japan

4. General Internal Medicine Taihaku Avenue Clinic Fukuoka Japan

Publisher

Wiley

Subject

Infectious Diseases,Virology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jmv.27904

Reference34 articles.

1. Natural history of hepatitis C

2. Telaprevir can be successfully and safely used to treat older patients with genotype 1b chronic hepatitis C

3. NS5A resistance-associated variants undermine the effectiveness of ledipasvir and sofosbuvir for cirrhotic patients infected with HCV genotype 1b

4. Association Between Sustained Virological Response and All-Cause Mortality Among Patients With Chronic Hepatitis C and Advanced Hepatic Fibrosis

5. Short-term risk of hepatocellular carcinoma after hepatitis C virus eradication following direct-acting anti-viral treatment

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of donor HSD17B13 genotype on patient survival after liver transplant: a retrospective cohort study;eClinicalMedicine;2024-01